advertisement
Ohguro H 23
Showing records 1 to 23 | Display only abstracts from Ohguro H in IGR 25-1124302 High Intraocular Pressure Is Independently Associated With New-Onset Systemic Hypertension Over a 10-Year Period
Umetsu A; Tanaka M; Sato T; Akiyama Y; Endo K; Mori K; Ohnishi H; Watanabe M; Ohguro H; Hanawa N; Furuhashi M
Circulation journal : official journal of the Japanese Circulation Society 2024; 88: 1689-1696 (IGR: 25-1)
118273 Differential Effects of Benzalkonium Chloride on Human Trabecular Meshwork Cells Not Treated or Treated with Transforming Growth Factor-β2 or Dexamethasone
Watanabe M; Sato T; Umetsu A; Nishikiori N; Higashide M; Furuhashi M; Ohguro H
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 189-196 (IGR: 24-4)
107900 TGF-β-3 Induces Different Effects from TGF-β-1 and -2 on Cellular Metabolism and the Spatial Properties of the Human Trabecular Meshwork Cells
Watanabe M; Sato T; Tsugeno Y; Higashide M; Furuhashi M; Ohguro H
International journal of molecular sciences 2023; 24: (IGR: 23-4)
105132 All- Retinoic Acids Synergistically and Beneficially Affect In Vitro Glaucomatous Trabecular Meshwork (TM) Models Using 2D and 3D Cell Cultures of Human TM Cells
Watanabe M; Sato T; Tsugeno Y; Higashide M; Furuhashi M; Umetsu A; Suzuki S; Ida Y; Hikage F; Ohguro H
International journal of molecular sciences 2022; 23: (IGR: 23-2)
91139 ROCK inhibitors beneficially alter the spatial configuration of TGFβ2-treated 3D organoids from a human trabecular meshwork (HTM)
Ota C; Ida Y; Ohguro H; Hikage F
Scientific reports 2020; 10: 20292 (IGR: 21-4)
55430 Effects of several anti-glaucoma medications on the circadian intraocular pressure fluctuations in patients with primary open-angle glaucoma
Tanaka S; Watanabe M; Inatomi S; Umeda K; Yoshida K; Ohguro I; Ohguro H
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 12-20 (IGR: 15-4)
51986 Black Currant Anthocyanins Normalized Abnormal Levels of Serum Concentrations of Endothelin-1 in Patients with Glaucoma
Yoshida K; Ohguro I; Ohguro H
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 480-487 (IGR: 14-4)
51668 Effects of black currant anthocyanins on intraocular pressure in healthy volunteers and patients with glaucoma
Ohguro H; Ohguro I; Yagi S
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 61-67 (IGR: 14-4)
49130 Two-Year Randomized, Placebo-Controlled Study of Black Currant Anthocyanins on Visual Field in Glaucoma
Ohguro H; Ohguro I; Katai M; Tanaka S
Ophthalmologica 2012; 228: 26-35 (IGR: 14-1)
27489 Clinical distinction between nasal optic disc hypoplasia (NOH) and glaucoma with NOH-like temporal visual field defects
Ohguro H; Ohguro I; Tsuruta M; Katai M; Tanaka S
Clinical Ophthalmology 2010; 4: 547-555 (IGR: 12-4)
19712 Physiological and clinical aspects of the neuroretinal circuit, (4): Diseases of the 2nd and 3rd retinal neurons
Ohguro H; Kawata H; Matsuo S; Hashimoto M
Neuro-Ophthalmology Japan 2007; 24: 353-360 (IGR: 9-4)
12674 Optic disc characteristics assessed by evaluation of clinical optic disc photographs in glaucoma patients
Ohguro I; Ohguro H; Ohkuro H; Nakazawa M
Hirosaki Medical Journal 2005; 57: 27-34 (IGR: 7-3)
13115 Study of effects of antiglaucoma eye drops on N-methyl-d: -aspartate-induced retinal damage
Metoki T; Ohguro H; Ohguro I; Mamiya K; Ito T; Nakazawa M
Japanese Journal of Ophthalmology 2005; 49: 453-461 (IGR: 7-3)
11812 Change of retinal ganglion cells in the ocular hyertension model rat
Ito T; Ohguro H; Ohguro I; Mamiya K; Ishikawa F; Metoki T; Yamazaki H; Takano Y; Nakazawa M; Shoumura K
Hirosaki Medical Journal 2004; 56: 15-20 (IGR: 7-1)
11295 Effects of matrix metalloproteinase-3 gene transfer by electroporation in glaucoma filter surgery
Mamiya K; Ohguro H; Ohguro I; Metoki T; Ishikawa F; Yamazaki H; Takano Y; Ito T; Nakazawa M
Experimental Eye Research 2004; 79: 405-410 (IGR: 6-3)
8744 Clinical roles of serum autoantibody against neuron-specific enolase in glaucoma patients
Maruyama I; Ikeda Y; Nakazawa M; Ohguro H
Tohoku Journal of Experimental Medicine 2002; 197: 125-132 (IGR: 5-1)
6677 Autoantibody against neuron-specific enolase found in glaucoma patients causes retinal dysfunction in vivo
Maruyama I; Maeda T; Okisaka S; Mizukawa A; Nakazawa M; Ohguro H
Japanese Journal of Ophthalmology 2002; 46: 1-12 (IGR: 4-1)
6763 Clinical significance of serum antibody against neuron-specific enolase in glaucoma patients
Ikeda Y; Maruyama I; Nakazawa M; Ohguro H
Japanese Journal of Ophthalmology 2002; 46: 13-17 (IGR: 4-1)
6770 A Case of acute angle-closure glaucoma secondary to posterior scleritis in patient with Sturge-Weber syndrome
Maruyama I; Ohguro H; Nakazawa M
Japanese Journal of Ophthalmology 2002; 46: 74-77 (IGR: 4-1)
6854 Preservation of retinal morphology and functions in Royal College Surgeons rat by nilvadipine, a Ca2+ antagonist
Yamazaki H; Ohguro H; Maeda T; Maruyama I; Takano Y; Metoki T; Nakazawa M; Sawada H; Dezawa M
Investigative Ophthalmology and Visual Science 2002; 43: 919-926 (IGR: 4-1)
18277 A case of malignant glaucoma following trabeculectomy for open-angle glaucoma secondary to carotid cavernous sinus fistula
Nakamura S; Ohguro H; Funahashi K; Maeda K; Maruyama I
Japanese Journal of Clinical Ophthalmology 2001; 55: 1563-1567 (IGR: 3-3)
15818 Two cases of primary open-angle glaucoma with serum autoantibody against retinal ganglion cells
Ikeda Y; Ohguro H; Maruyama I
Japanese Journal of Ophthalmology 2000; 44: 648-652 (IGR: 2-3)
5959 Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients
Maruyama I; Ohguro H; Ikeda Y
Investigative Ophthalmology and Visual Science 2000; 41: 1657-1665 (IGR: 2-2)
